1,2-dimethylhydrazine multiple interactions ISO Slc31a2 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of SLC31A2 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO Slc31a2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of SLC31A2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLC31A2 mRNA CTD PMID:17351261 17beta-estradiol decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Estradiol results in decreased expression of SLC31A2 mRNA CTD PMID:24758408 and PMID:31614463 17beta-estradiol multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 EGF protein promotes the reaction [Estradiol results in decreased expression of SLC31A2 mRNA] CTD PMID:24758408 2,2,2-tetramine multiple interactions EXP 6480464 Trientine promotes the reaction [Streptozocin results in increased expression of SLC31A2 mRNA] and Trientine promotes the reaction [Streptozocin results in increased expression of SLC31A2 protein] CTD PMID:24927960 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc31a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC31A2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC31A2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC31A2 mRNA CTD PMID:34747641 3,4-methylenedioxymethamphetamine decreases expression ISO Slc31a2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SLC31A2 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation ISO Slc31a2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of SLC31A2 promoter CTD PMID:26251327 4-hydroxyphenyl retinamide increases expression ISO Slc31a2 (Mus musculus) 6480464 Fenretinide results in increased expression of SLC31A2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC31A2 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC31A2 mRNA CTD PMID:30047161 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC31A2 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO SLC31A2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SLC31A2 mRNA CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO SLC31A2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SLC31A2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO SLC31A2 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC31A2 mRNA CTD PMID:23724009 and PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of SLC31A2 mRNA CTD PMID:30047161 antirheumatic drug decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of SLC31A2 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO Slc31a2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC31A2 mRNA CTD PMID:23650126 bathocuproine disulfonic acid multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein] which results in increased uptake of and results in increased susceptibility to Cisplatin and [bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein CTD PMID:20194531 bathocuproine disulfonic acid affects localization ISO SLC31A2 (Homo sapiens) 6480464 bathocuproine sulfonate affects the localization of SLC31A2 protein CTD PMID:20194531 bathocuproine disulfonic acid multiple interactions ISO Slc31a2 (Mus musculus) 6480464 ATOX1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 mRNA] and ATOX1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein] CTD PMID:20194531 benzo[a]pyrene increases expression ISO Slc31a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC31A2 mRNA CTD PMID:21715664 and PMID:22228805 benzo[a]pyrene decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC31A2 mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I increases expression ISO SLC31A2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC31A2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO Slc31a2 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC31A2 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC31A2 mRNA CTD PMID:30816183 more ... bisphenol F increases expression ISO Slc31a2 (Mus musculus) 6480464 bisphenol F results in increased expression of SLC31A2 mRNA CTD PMID:30951980 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SLC31A2 mRNA CTD PMID:19167457 calcitriol increases expression ISO SLC31A2 (Homo sapiens) 6480464 Calcitriol results in increased expression of SLC31A2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC31A2 mRNA CTD PMID:21592394 carbamazepine affects expression ISO SLC31A2 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC31A2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Slc31a2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carboplatin decreases uptake ISO Slc31a2 (Mus musculus) 6480464 SLC31A2 protein results in decreased uptake of Carboplatin CTD PMID:19509135 CGP 52608 multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC31A2 gene] CTD PMID:28238834 chlordecone increases expression ISO Slc31a2 (Mus musculus) 6480464 Chlordecone results in increased expression of SLC31A2 mRNA CTD PMID:33711761 chlorpyrifos increases expression ISO Slc31a2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC31A2 mRNA CTD PMID:37019170 cisplatin multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein] which results in increased uptake of and results in increased susceptibility to Cisplatin and [Copper deficiency results in decreased expression of SLC31A2 protein] which results in increased uptake of and results in increased susceptibility to Cisplatin CTD PMID:20194531 cisplatin affects response to substance ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 protein affects the susceptibility to Cisplatin CTD PMID:23564780 cisplatin decreases response to substance ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 protein results in decreased susceptibility to Cisplatin CTD PMID:24522273 cisplatin decreases uptake ISO Slc31a2 (Mus musculus) 6480464 SLC31A2 protein results in decreased uptake of Cisplatin CTD PMID:19509135 and PMID:20930109 cisplatin affects uptake ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 protein affects the uptake of Cisplatin CTD PMID:19509135 cisplatin multiple interactions ISO Slc31a2 (Mus musculus) 6480464 ATOX1 protein affects the reaction [Cisplatin results in increased expression of SLC31A2 mRNA] more ... CTD PMID:20194531 and PMID:24167251 cisplatin increases expression ISO SLC31A2 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC31A2 mRNA and Cisplatin results in increased expression of SLC31A2 protein CTD PMID:20194531 and PMID:27392435 cisplatin decreases degradation ISO SLC31A2 (Homo sapiens) 6480464 Cisplatin results in decreased degradation of SLC31A2 protein CTD PMID:20194531 cisplatin affects localization ISO SLC31A2 (Homo sapiens) 6480464 Cisplatin affects the localization of SLC31A2 protein CTD PMID:20194531 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SLC31A2 mRNA CTD PMID:24386269 copper atom affects abundance ISO Slc31a2 (Mus musculus) 6480464 SLC31A2 protein affects the abundance of Copper CTD PMID:20930109 copper atom increases abundance ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 protein results in increased abundance of Copper CTD PMID:24522273 copper atom affects uptake ISO Slc31a2 (Mus musculus) 6480464 SLC31A2 protein affects the uptake of Copper CTD PMID:19509135 copper atom increases uptake ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 protein results in increased uptake of Copper CTD PMID:17944601 copper atom multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein] which results in increased uptake of and results in increased susceptibility to Cisplatin more ... CTD PMID:17944601 and PMID:20194531 copper atom multiple interactions ISO Slc31a2 (Mus musculus) 6480464 [SLC31A2 protein results in increased expression of SLC31A1 protein modified form] which results in decreased abundance of Copper more ... CTD PMID:20194531 and PMID:24167251 copper atom decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Copper deficiency results in decreased expression of SLC31A2 protein CTD PMID:20194531 copper atom increases degradation ISO Slc31a2 (Mus musculus) 6480464 Copper deficiency results in increased degradation of SLC31A2 protein CTD PMID:20930109 copper(0) affects abundance ISO Slc31a2 (Mus musculus) 6480464 SLC31A2 protein affects the abundance of Copper CTD PMID:20930109 copper(0) increases abundance ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 protein results in increased abundance of Copper CTD PMID:24522273 copper(0) affects uptake ISO Slc31a2 (Mus musculus) 6480464 SLC31A2 protein affects the uptake of Copper CTD PMID:19509135 copper(0) increases uptake ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 protein results in increased uptake of Copper CTD PMID:17944601 copper(0) multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein] which results in increased uptake of and results in increased susceptibility to Cisplatin more ... CTD PMID:17944601 and PMID:20194531 copper(0) multiple interactions ISO Slc31a2 (Mus musculus) 6480464 [SLC31A2 protein results in increased expression of SLC31A1 protein modified form] which results in decreased abundance of Copper more ... CTD PMID:20194531 and PMID:24167251 copper(0) decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Copper deficiency results in decreased expression of SLC31A2 protein CTD PMID:20194531 copper(0) increases degradation ISO Slc31a2 (Mus musculus) 6480464 Copper deficiency results in increased degradation of SLC31A2 protein CTD PMID:20930109 copper(II) sulfate increases expression ISO SLC31A2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of SLC31A2 mRNA and Copper Sulfate results in increased expression of SLC31A2 protein CTD PMID:20194531 copper(II) sulfate affects localization ISO SLC31A2 (Homo sapiens) 6480464 Copper Sulfate affects the localization of SLC31A2 protein CTD PMID:20194531 copper(II) sulfate decreases degradation ISO SLC31A2 (Homo sapiens) 6480464 Copper Sulfate results in decreased degradation of SLC31A2 protein CTD PMID:20194531 crocidolite asbestos decreases expression ISO Slc31a2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of SLC31A2 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC31A2 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC31A2 mRNA CTD PMID:23640034 dexamethasone decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of SLC31A2 mRNA CTD PMID:25047013 dextran decreases uptake ISO Slc31a2 (Mus musculus) 6480464 SLC31A2 protein results in decreased uptake of Dextrans CTD PMID:20930109 dibutyl phthalate increases expression ISO Slc31a2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of SLC31A2 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO SLC31A2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of SLC31A2 mRNA CTD PMID:28302478 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of SLC31A2 mRNA CTD PMID:23153324 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SLC31A2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A2 mRNA CTD PMID:27188386 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of SLC31A2 mRNA CTD PMID:29391264 ethyl methanesulfonate increases expression ISO SLC31A2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of SLC31A2 mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO Slc31a2 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC31A2 mRNA CTD PMID:28329830 folic acid multiple interactions ISO Slc31a2 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of SLC31A2 mRNA] CTD PMID:22206623 formaldehyde increases expression ISO SLC31A2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of SLC31A2 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC31A2 mRNA CTD PMID:22061828 glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of SLC31A2 mRNA CTD PMID:26302742 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of SLC31A2 mRNA CTD PMID:23153324 lipopolysaccharide increases expression ISO Slc31a2 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of SLC31A2 mRNA CTD PMID:22369063 and PMID:25890327 methotrexate increases expression ISO SLC31A2 (Homo sapiens) 6480464 Methotrexate results in increased expression of SLC31A2 mRNA CTD PMID:19100307 methyl methanesulfonate increases expression ISO SLC31A2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of SLC31A2 mRNA CTD PMID:23649840 mirex decreases expression EXP 6480464 Mirex results in decreased expression of SLC31A2 mRNA CTD PMID:23153324 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC31A2 mRNA CTD PMID:33387578 paraquat increases expression ISO SLC31A2 (Homo sapiens) 6480464 Paraquat results in increased expression of SLC31A2 mRNA CTD PMID:34097952 perfluorononanoic acid decreases expression ISO SLC31A2 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLC31A2 mRNA CTD PMID:32588087 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of SLC31A2 mRNA CTD PMID:30047161 SB 431542 multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A2 mRNA CTD PMID:27188386 senecionine decreases expression ISO Slc31a2 (Mus musculus) 6480464 senecionine results in decreased expression of SLC31A2 protein CTD PMID:35357534 silicon dioxide increases expression ISO SLC31A2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SLC31A2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Slc31a2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of SLC31A2 mRNA CTD PMID:29203145 silver atom multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 Silver inhibits the reaction [SLC31A2 protein results in increased uptake of Copper] CTD PMID:17944601 silver(0) multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 Silver inhibits the reaction [SLC31A2 protein results in increased uptake of Copper] CTD PMID:17944601 Soman increases expression EXP 6480464 Soman results in increased expression of SLC31A2 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 Trientine promotes the reaction [Streptozocin results in increased expression of SLC31A2 mRNA] and Trientine promotes the reaction [Streptozocin results in increased expression of SLC31A2 protein] CTD PMID:24927960 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of SLC31A2 mRNA and Streptozocin results in increased expression of SLC31A2 protein CTD PMID:24927960 succimer multiple interactions ISO Slc31a2 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC31A2 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC31A2 mRNA CTD PMID:21641980 and PMID:26378955 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of SLC31A2 mRNA CTD PMID:30047161 sunitinib decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SLC31A2 mRNA CTD PMID:31533062 temozolomide decreases expression ISO SLC31A2 (Homo sapiens) 6480464 Temozolomide results in decreased expression of SLC31A2 mRNA CTD PMID:31758290 testosterone multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC31A2 mRNA CTD PMID:21592394 testosterone increases expression ISO SLC31A2 (Homo sapiens) 6480464 Testosterone results in increased expression of SLC31A2 mRNA CTD PMID:21592394 tetrathiomolybdate(2-) decreases response to substance ISO SLC31A2 (Homo sapiens) 6480464 SLC31A2 mRNA results in decreased susceptibility to tetrathiomolybdate CTD PMID:24522273 trimellitic anhydride decreases expression ISO Slc31a2 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of SLC31A2 mRNA CTD PMID:19042947 valproic acid affects expression ISO SLC31A2 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC31A2 mRNA CTD PMID:25979313 valproic acid increases expression ISO SLC31A2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC31A2 mRNA CTD PMID:22083351 more ... valproic acid multiple interactions ISO SLC31A2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A2 mRNA CTD PMID:27188386 zidovudine increases expression ISO SLC31A2 (Homo sapiens) 6480464 Zidovudine results in increased expression of SLC31A2 mRNA CTD PMID:24292225 zinc dichloride increases expression ISO SLC31A2 (Homo sapiens) 6480464 zinc chloride results in increased expression of SLC31A2 mRNA CTD PMID:18947441 zinc dichloride decreases expression ISO SLC31A2 (Homo sapiens) 6480464 zinc chloride results in decreased expression of SLC31A2 mRNA CTD PMID:18947441